CD8A and Merkel cell skin cancer: A recent study developed a means of improving autologous CD8 T cell therapeutic vaccines for MCC by exposing those T cells to cytokine-conditioned dendritic cells presenting LTT peptides on both MHC-I and II surface receptors (Gerer et al., 2017).